FBInvestor
Stocks / Ernexa Therapeutics Inc
Institutional Ownership

Ernexa Therapeutics Inc

CUSIP 114082308COMQ1 2026

Institutional Holders
18
13F filers
Shares Held
3.52M
Aggregate institutional
Institutional Value
$701.1K
Q1 2026
Net New Holders
+5
9 new · 4 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions9
Increased3
Decreased0
Sold out4

Institutional Holders

18 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Bleichroeder LP2.00M$398.0K+2.00MNew
2Dauntless Investment Group, LLC612.4K$121.9K+612.4KNew
3Corient Private Wealth LLC438.1K$87.2K+1Added
4Geode Capital Management, LLC244.4K$48.6K+220.8KAdded
5Xtx Topco Ltd54.3K$10.8K+54.3KNew
6Warberg Asset Management LLC50.0K$10.1K+50.0KNew
7Jane Street Group, LLC41.2K$8.2K+41.2KNew
8Citadel Advisors LLC33.1K$6.6K+33.1KNew
9Ubs Group AG21.2K$4.2K+20.6KAdded
10Goldman Sachs Group Inc16.6K$3.3K+16.6KNew

8 more institutional holders on Premium

See every fund holding Ernexa Therapeutics Inc, with full quarter-over-quarter share changes.

Unlock all holders